Jiang, X., Shen, H., Mager, D. E., & Yu, A. (2013). Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status. The American Society for Pharmacology and Experimental Therapeutics.
Dyfyniad Arddull ChicagoJiang, Xi-Ling, Hong-Wu Shen, Donald E. Mager, and Ai-Ming Yu. Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status. The American Society for Pharmacology and Experimental Therapeutics, 2013.
Dyfyniad MLAJiang, Xi-Ling, Hong-Wu Shen, Donald E. Mager, and Ai-Ming Yu. Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status. The American Society for Pharmacology and Experimental Therapeutics, 2013.